Anika Therapeutics (ANIK) Return on Capital Employed Growth (1y) (2012 - 2026)
Anika Therapeutics (ANIK) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.58 Bn | 86.72 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.33 Bn | 30.39 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.29 Bn | 18.49 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.93 Bn | 16.62 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn | 1,195.00 |
| 10 | Anika Therapeutics | 204.72 Mn | 137.94 Mn | 19.00 Mn | -363.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -363.00 |
| Dec 31, 2025 | -395.00 |
| Sep 30, 2025 | -1,648.00 |
| Jun 30, 2025 | -1,071.00 |
| Mar 31, 2025 | -841.00 |
| Dec 31, 2024 | -295.00 |
| Sep 30, 2024 | 1,165.00 |
| Jun 30, 2024 | 716.00 |
| Mar 31, 2024 | 625.00 |
| Dec 31, 2023 | -83.00 |
| Sep 30, 2023 | 425.00 |
| Jun 30, 2023 | 283.00 |
| Mar 31, 2023 | -100.00 |
| Dec 31, 2022 | 33.00 |
| Sep 30, 2022 | -485.00 |
| Jun 30, 2022 | 18.00 |
| Mar 31, 2022 | 1,009.00 |
| Dec 31, 2021 | 881.00 |
| Sep 30, 2021 | -49.00 |
| Jun 30, 2021 | -848.00 |